Anupam has been working as the Senior Vice President and global head of safety & PV at Denovo Biopharma for a year. He has been working in the pharmaceutical industry for 17 years. He worked in many therapeutic areas throughout his career, including cardiovascular, respiratory, anti-inflammatory, GI, oncology, CNS, and Alzheimer’s disease.
He is a cardiologist with over two decades of experience treating patients and clinical research in academia. He researched the genetics of hypertension; drug eluted coronary stents at Brigham and Women’s Hospital. In addition, Anupam is a member of the scientific oversight committee at the Cardiac Safety Research Consortium (CSRC), a think tank launched through an FDA Critical Path Initiative with Duke University. Anupam holds a medical degree from India and a Master of Public Health (MPH) with a concentration in clinical research from Harvard. He also sits on the board of directors at Alliance for Artificial Intelligence in Healthcare.
